微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Rhodococcus equi (Magnusson) Goodfellow and Alderson |
|---|---|
| 商品货号： | TS145880 |
| Deposited As： | Corynebacterium equi Magnusson |
| Strain Designations： | 13-9 |
| Application： | Degrades levulinic acid |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | Kikkoman Shioyu Co., Ltd. |
| U.S. Patent Number： | |
| References： | Ueno T, Harada M. Method for removing levulinic acid by microorganisms. US Patent 3,663,368 dated May 16 1972 |